Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

BMI, body mass index; HRT, hormone replacement therapy; VitD, vitamin D; Ca, serum total calcium; Pi, serum phosphate; ALP, serum alkaline phosphatase; iPTH, serum intact parathyroid hormone; 25(OH)D, 25-hydroxy vitamin D; β-CTX, C-terminal cross-linking telopeptide of type I collagen; P1NP, procollagen type 1 N-terminal propeptide; ALT, alanine aminotransferase; Cr, serum creatinine; aBMD, areal bone mineral density; L1-4, lumbar vertebrae 1-4; TUG, Timed Up and Go; FROP-Com, the Fall Risk for Older People in the Community.

Source: Baseline characteristics of the cohort. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This was a cross-sectional study in community-dwelling postmenopausal women based on the Beijing subgroup of the Chinese Vertebral Osteoporosis Study (ChiVos).

Source: Methods.

138 participants were enrolled from September 2021 to December 2021.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association of serum periostin with bone microarchitecture, muscle mass and function in Chinese postmenopausal women

Cross-sectional study · Frontiers in Endocrinology · 2026

Original publication title

Association of serum periostin with bone microarchitecture, muscle mass and function in Chinese postmenopausal women

Yiyi Gong; Yushuo Wu; Xiaosen Ma; Lijia Cui; Xiang Li; Qianqian Pang; Yue Chi; Ruizhi Jiajue; Wei Liu; Ou Wang; Mei Li; Xiaoping Xing; Zaizhu Zhang; Wei Yu; Yan Jiang; Weibo Xia

Copyright © 2026 Gong, Wu, Ma, Cui, Li, Pang, Chi, Jiajue, Liu, Wang, Li, Xing, Zhang, Yu, Jiang and Xia.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Higher serum periostin is associated with smaller bone cross-sectional area, lower estimated bone strength, reduced muscle mass, and higher fall risk, indicating its potential as a predictor for assessing skeletal and muscular health in postmenopausal women.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

High serum periostin is linked to an increased risk of osteoporotic fractures in postmenopausal women. However, the relationships between serum periostin and bone microarchitecture, particularly muscle mass, and muscle function remain unclear. This study aims to investigate the relationships between serum periostin and bone mineral density, bone microarchitecture, muscle mass and function, falls, and fractures in community-dwelling Chinese postmenopausal women.

Source: Purpose

Abstract: What methods does the paper describe?

Serum periostin levels were measured in 135 Chinese postmenopausal women. Dual-energy X-ray absorptiometry assessed areal bone mineral density (aBMD), lumbar trabecular bone score (TBS), and muscle mass. High-resolution peripheral quantitative computed tomography (HR-pQCT) evaluated bone microarchitecture. Muscle function and fall risk were assessed using handgrip strength, the Short Physical Performance Battery (SPPB), the Timed Up and Go (TUG) test, and the Falls Risk for Older People in the Community (FROP-Com) screening tool.

Source: Method

Abstract: Result

The mean serum periostin was 1770.3 ± 440.4 pmol/L. Serum periostin was negatively correlated with bone microarchitecture parameters, total area (Tot.Ar), cortical perimeter (Ct.Pm), trabecular area (Tb.Ar), estimated bone strength stiffness, and failure load. Negative correlations were also found with appendicular skeletal muscle mass (ASM), balance test scores, and gait speed. Conversely, serum periostin was positively correlated with TUG time and FROP-Com scores.

Source: Result

Abstract: Conclusion

Higher serum periostin is associated with smaller bone cross-sectional area, lower estimated bone strength, reduced muscle mass, and higher fall risk, indicating its potential as a predictor for assessing skeletal and muscular health in postmenopausal women.

Source: Conclusion
Authors’ abstract

Purpose

High serum periostin is linked to an increased risk of osteoporotic fractures in postmenopausal women. However, the relationships between serum periostin and bone microarchitecture, particularly muscle mass, and muscle function remain unclear. This study aims to investigate the relationships between serum periostin and bone mineral density, bone microarchitecture, muscle mass and function, falls, and fractures in community-dwelling Chinese postmenopausal women.

Method

Serum periostin levels were measured in 135 Chinese postmenopausal women. Dual-energy X-ray absorptiometry assessed areal bone mineral density (aBMD), lumbar trabecular bone score (TBS), and muscle mass. High-resolution peripheral quantitative computed tomography (HR-pQCT) evaluated bone microarchitecture. Muscle function and fall risk were assessed using handgrip strength, the Short Physical Performance Battery (SPPB), the Timed Up and Go (TUG) test, and the Falls Risk for Older People in the Community (FROP-Com) screening tool.

Result

The mean serum periostin was 1770.3 ± 440.4 pmol/L. Serum periostin was negatively correlated with bone microarchitecture parameters, total area (Tot.Ar), cortical perimeter (Ct.Pm), trabecular area (Tb.Ar), estimated bone strength stiffness, and failure load. Negative correlations were also found with appendicular skeletal muscle mass (ASM), balance test scores, and gait speed. Conversely, serum periostin was positively correlated with TUG time and FROP-Com scores.

Conclusion

Higher serum periostin is associated with smaller bone cross-sectional area, lower estimated bone strength, reduced muscle mass, and higher fall risk, indicating its potential as a predictor for assessing skeletal and muscular health in postmenopausal women.

Publication and source details

Original title: Association of serum periostin with bone microarchitecture, muscle mass and function in Chinese postmenopausal women

Yiyi Gong; Yushuo Wu; Xiaosen Ma; Lijia Cui; Xiang Li; Qianqian Pang; Yue Chi; Ruizhi Jiajue; Wei Liu; Ou Wang; Mei Li; Xiaoping Xing; Zaizhu Zhang; Wei Yu; Yan Jiang; Weibo Xia

Frontiers in Endocrinology · 2026

* Correspondence: Yan Jiang, sinojenny@126.com; Weibo Xia, xiaweibo8301@163.com

†These authors have contributed equally to this work

Copyright © 2026 Gong, Wu, Ma, Cui, Li, Pang, Chi, Jiajue, Liu, Wang, Li, Xing, Zhang, Yu, Jiang and Xia.2026Gong, Wu, Ma, Cui, Li, Pang, Chi, Jiajue, Liu, Wang, Li, Xing, Zhang, Yu, Jiang and Xiahttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This research was supported by Noncommunicable Chronic Diseases-National Science and Technology Major Project (2024ZD0532204); National Key R&D Program of China (2021YFC2501700); Independent Research Fund of the State Key Laboratory of Complex, Severe, and Rare Disease (2025-I-PY-007); National High Level Hospital Clinical Research Funding (2022-PUMCH-D-006); the National Natural Science Foundation of China (No.82100942, No.82270938, No.81970757, 82571025); the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2023-PT320-10); Beijing Natural Science Foundation (7242106); CAMS Innovation Fund for medical Sciences (CIFMS) (2025-I2M-XHXX-003).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:29:29.260106+00:00

DOI: 10.3389/fendo.2026.1808866 · PMC13095588